CSIMarket


Johnson and Johnson  (JNJ)
Other Ticker:  
 

Johnson and Johnson

JNJ's Fundamental analysis








Johnson And Johnson's sales fell by -13.59 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 2454

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -0.33 %

Johnson And Johnson realized net income compared to net loss a year ago in I. Quarter 2024

More on JNJ's Growth


Johnson And Johnson
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Johnson And Johnson PEG ratio is at 0.04 Johnson And Johnson realized cash outflow of $ -0.57per share in trailing twelve-month period.
Company
9.58
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.94.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.45.


More on JNJ's Valuation
 
 Total Debt (Millions $) 33,632
 Dividend TTM ($) 4.6 $
 Dividend Yield TTM (%) 3.24 %
 Revenue/Employee (TTM) $ 632,738
 Net Income/Employee (TTM) $ 271,531
 Receivable Turnover (TTM) 5.84
 Tangible Book Value (Per Share $) -0.36

Johnson And Johnson
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Johnson And Johnson PEG ratio is at 0.04 Johnson And Johnson realized cash outflow of $ -0.57per share in trailing twelve-month period.
Company
9.58
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.94.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.45.

Johnson And Johnson Price to Book Ratio is at 5.05 lower than Indusry Avg. of 76.56. and higher than S&P 500 Avg. of 0.01

More on JNJ's Valuation

  Market Capitalization (Millions $) 353,677
  Shares Outstanding (Millions) 2,430
  Employees 141,700
  Revenues (TTM) (Millions $) 89,659
  Net Income (TTM) (Millions $) 38,476
  Cash Flow (TTM) (Millions $) -1,392
  Capital Exp. (TTM) (Millions $) -4,487
  Total Debt (Millions $) 33,632
  Dividend TTM ($) 4.6 $
  Dividend Yield TTM (%) 3.24 %
  Revenue/Employee (TTM) $ 632,738
  Net Income/Employee(TTM) $ 271,531
  Receivable Turnover Ratio (TTM) 5.84
  Tangible Book Value (Per Share $) -0.36

  Market Capitalization (Millions $) 353,677
  Shares Outstanding (Millions) 2,430
  Employees 141,700
  Revenues (TTM) (Millions $) 89,659
  Net Income (TTM) (Millions $) 38,476
  Cash Flow (TTM) (Millions $) -1,392
  Capital Exp. (TTM) (Millions $) -4,487


    JNJ's Profitability Comparisons
Johnson And Johnson achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2024 to 27.63 %.

Johnson And Johnson net profit margin of 15.22 % is currently ranking no. 26 in Major Pharmaceutical Preparations industry, ranking no. 57 in Healthcare sector and number 751 in S&P 500.


Profitability by Segment
Total Pharmaceutical 57.17 %
Med. Dev. & Diag. 47.39 %
Total Consumer 38.9 %



  Ratio
   Capital Ratio (MRQ) 1.75
  Total Debt to Equity (MRQ) 0.48
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.54
  Inventory Turnover Ratio (TTM) 2.12



Johnson And Johnson achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2024 to 27.63 %.

Johnson And Johnson net profit margin of 15.22 % is currently ranking no. 26 in Major Pharmaceutical Preparations industry, ranking no. 57 in Healthcare sector and number 751 in S&P 500.

More on JNJ's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com